http://www.chemocentryx.com
ChemoCentryx, Inc. Company Intro
Positive topline data from pivotal Phase III ADVOCATE trial demonstrates avacopan’s superiority over standard of care in ANCA-associated vasculitis.
Industry
Healthcare
ChemoCentryx, Inc. Headquaters
850 Maude Avenue
Mountain View,94043
United States
ChemoCentryx, Inc. Share price
14 Sep 2022 08:52 GMT
$51.47
-0.03 (-0.06 %)
ChemoCentryx, Inc. Market cap
$3.598 B
WMC RANKING
2023
ChemoCentryx, Inc. # 83
BiotechnologyLatest ChemoCentryx, Inc. News
03 Feb 2023
Oncolytic Virus Cancer Therapy Market growing at a ...
... in the Oncolytic Virus Cancer market are Oncolytics Biotech Inc, Amgen Inc., ... to pay $3.7 billion for the biopharma firm ChemoCentryx in August 2022.
03 Feb 2023
Birchview Capital, LP Buys 2,
In terms of valuation, Biohaven Pharmaceutical Holding Co Ltd has a EV-to-Ebitda ratio of -15.28 and a price-sales ratio of 1.13. ChemoCentryx Inc. The guru...
03 Feb 2023
Oncolytic Virus Cancer Therapy Market growing at a ...
... in the Oncolytic Virus Cancer market are Oncolytics Biotech Inc, Amgen Inc., ... to pay $3.7 billion for the biopharma firm ChemoCentryx in August 2022.
WMC Market Score
WMC Market to Revenue Score
ChemoCentryx, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| ChemoCentryx, Inc. | USD | $68,760 | $131,141 | $-63,380 | $35,980B | 83 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total ChemoCentryx, Inc. Social Followers vs Top 4 Industry Competitors
ChemoCentryx, Inc. Post vs Top 4 Industry Competitors
ChemoCentryx, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
ChemoCentryx, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
ChemoCentryx, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| ChemoCentryx, Inc. | 0.75 | 2.86 | 0.02 | 0 | 0 | 0 | 1.30 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
